OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Brain Penetrant, but not Peripherally Restricted, Synthetic Cannabinoid 1 Receptor Agonists Promote Morphine-Mediated Respiratory Depression
Beth M. Wiese, Erika Liktor‐Busa, Sarah Couture, et al.
Cannabis and Cannabinoid Research (2021) Vol. 7, Iss. 5, pp. 621-627
Open Access | Times Cited: 7
Beth M. Wiese, Erika Liktor‐Busa, Sarah Couture, et al.
Cannabis and Cannabinoid Research (2021) Vol. 7, Iss. 5, pp. 621-627
Open Access | Times Cited: 7
Showing 7 citing articles:
Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review
Kuldeep Singh, Bharat Bhushan, Dilip Kumar Chanchal, et al.
Behavioural Neurology (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 21
Kuldeep Singh, Bharat Bhushan, Dilip Kumar Chanchal, et al.
Behavioural Neurology (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 21
Endogenous opiates and behavior: 2022
Richard J. Bodnar
Peptides (2023) Vol. 169, pp. 171095-171095
Closed Access | Times Cited: 13
Richard J. Bodnar
Peptides (2023) Vol. 169, pp. 171095-171095
Closed Access | Times Cited: 13
Respiratory System
Jean-Paul Henri Dedam, Matthew Fogel, Elizabeth Fogel
(2025), pp. 45-50
Closed Access
Jean-Paul Henri Dedam, Matthew Fogel, Elizabeth Fogel
(2025), pp. 45-50
Closed Access
The endocannabinoid system and breathing
Beth M. Wiese, Angelica Alvarez Reyes, Todd W. Vanderah, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 8
Beth M. Wiese, Angelica Alvarez Reyes, Todd W. Vanderah, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 8
Potential Implications of Multi-Drug Exposure with Synthetic Cannabinoids: A Scoping Review of Human Case Studies
Lucy R. Thomsen, Rhonda J. Rosengren, Michelle Glass
Psychoactives (2024) Vol. 3, Iss. 3, pp. 365-383
Open Access | Times Cited: 2
Lucy R. Thomsen, Rhonda J. Rosengren, Michelle Glass
Psychoactives (2024) Vol. 3, Iss. 3, pp. 365-383
Open Access | Times Cited: 2
Inhaled Δ9-tetrahydrocannabinol does not enhance oxycodone-induced respiratory depression: randomised controlled trial in healthy volunteers
Cornelis Jan van Dam, Rutger van der Schrier, Monique van Velzen, et al.
British Journal of Anaesthesia (2023) Vol. 130, Iss. 4, pp. 485-493
Open Access | Times Cited: 3
Cornelis Jan van Dam, Rutger van der Schrier, Monique van Velzen, et al.
British Journal of Anaesthesia (2023) Vol. 130, Iss. 4, pp. 485-493
Open Access | Times Cited: 3
The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism
David B. Finlay, Warwick Mackie, Hunter D.J. Webb, et al.
Pharmacology Biochemistry and Behavior (2023) Vol. 223, pp. 173530-173530
Open Access | Times Cited: 2
David B. Finlay, Warwick Mackie, Hunter D.J. Webb, et al.
Pharmacology Biochemistry and Behavior (2023) Vol. 223, pp. 173530-173530
Open Access | Times Cited: 2
